CFM Wealth Partners’s Biogen BIIB Stock Holding History

CFM Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-368	Closed	-$98K	–	187
2020 Q2	$98K	Hold	368	–	–	0.04%	199
2020 Q1	$116K	Hold	368	–	–	0.05%	179
2019 Q4	$105K	Buy	+368	New	+$102K	0.04%	204

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CFM Wealth Partners's BIIB Position: Q3 2020 in Review

CFM Wealth Partners sold out of Biogen (BIIB) in Q3 2020, closing a stake of 368 shares — an estimated $98K sold.

CFM Wealth Partners first reported a position in BIIB in Q4 2019 and held it in 3 quarters. The position peaked at $116K in Q1 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

CFM Wealth Partners reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
CFM Wealth Partners sold 368 Biogen shares in Q3 2020, an estimated $98K.
CFM Wealth Partners first reported a position in Biogen in Q4 2019 and held it in 3 quarters.
CFM Wealth Partners's Biogen position peaked at $116K in Q1 2020.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on CFM Wealth Partners's 13F filing for Q3 2020, filed 10 Nov 2020.